1-20 of 21
indolent
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

How I treat a refractory myeloma patient who is not eligible for a clinical trial

Siyang Leng, Divaya Bhutani, Suzanne Lentzsch
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 125–136.
https://doi.org/10.1182/hematology.2019000016
Published: 2019
Journal Articles

Indolent lymphomas: pushing the pace with novel agents

Caron A. Jacobson
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 279–286.
https://doi.org/10.1182/hematology.2019000032
Published: 2019
Journal Articles

Molecular profiling and management of mantle cell lymphoma

Jia Ruan
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 30–40.
https://doi.org/10.1182/hematology.2019000011
Published: 2019
Journal Articles

Where does transplant fit in the age of targeted therapies?

Victor A. Chow, Ajay K. Gopal
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 287–293.
https://doi.org/10.1182/hematology.2019000033
Published: 2019
Journal Articles

Optimizing frontline therapy of CLL based on clinical and biological factors

Kirsten Fischer, Michael Hallek
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 338–345.
https://doi.org/10.1182/asheducation-2017.1.338
Published: 2017
Journal Articles

Optimizing therapy for mantle cell lymphoma

Peter Martin
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 304–309.
https://doi.org/10.1182/asheducation-2017.1.304
Published: 2017
Journal Articles

Prognostic factors in follicular lymphoma: new tools to personalize risk

Carla Casulo
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 269–276.
https://doi.org/10.1182/asheducation-2016.1.269
Published: 2016
Journal Articles

Management of symptoms in polycythemia vera and essential thrombocythemia patients

Deepti Radia, Holly L. Geyer
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 340–348.
https://doi.org/10.1182/asheducation-2015.1.340
Published: 2015
Journal Articles

What is the role of autologous transplant for lymphoma in the current era?

Patrick Stiff
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 74–81.
https://doi.org/10.1182/asheducation-2015.1.74
Published: 2015
Journal Articles

Diagnosis and management of mastocytosis: an emerging challenge in applied hematology

Peter Valent
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 98–105.
https://doi.org/10.1182/asheducation-2015.1.98
Published: 2015
Journal Articles

Management of prolymphocytic leukemia

Claire Dearden
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2015) 2015 (1): 361–367.
https://doi.org/10.1182/asheducation-2015.1.361
Published: 2015
Journal Articles

Hepatitis C virus-associated B-cell non-Hodgkin lymphomas

Barbara Vannata, Emanuele Zucca
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 590–598.
https://doi.org/10.1182/asheducation-2014.1.590
Published: 2014
Journal Articles

Lymphocyte-predominant Hodgkin lymphoma: what is the optimal treatment?

Michelle Fanale
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 406–413.
https://doi.org/10.1182/asheducation-2013.1.406
Published: 2013
Journal Articles

The many faces of marginal zone lymphoma

Pier Luigi Zinzani
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 426–432.
https://doi.org/10.1182/asheducation.V2012.1.426.3798535
Published: 2012
Journal Articles

Current treatment standards and emerging strategies in mantle cell lymphoma

Martin Dreyling, Wolfgang Hiddemann, for The European MCL Network
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2009) 2009 (1): 542–551.
https://doi.org/10.1182/asheducation-2009.1.542
Published: 2009
Journal Articles

Marginal Zone Lymphomas: Management of Nodal, Splenic, and MALT NHL

Brad Kahl, David Yang
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2008) 2008 (1): 359–364.
https://doi.org/10.1182/asheducation-2008.1.359
Published: 2008
Journal Articles

Reduced-Intensity Stem Cell Transplantation: “...whereof a little More than a little is by much too much.” King Henry IV, part 1, I, 2

Joseph H. Antin
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2007) 2007 (1): 47–54.
https://doi.org/10.1182/asheducation-2007.1.47
Published: 2007
Journal Articles

Hematopathology Approaches to Diagnosis and Prognosis of Indolent B-Cell Lymphomas

Randy D. Gascoyne
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2005) 2005 (1): 299–306.
https://doi.org/10.1182/asheducation-2005.1.299
Published: 2005
Journal Articles

Clinical Presentation and Management of Marginal Zone Lymphomas

Catherine Thieblemont
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2005) 2005 (1): 307–313.
https://doi.org/10.1182/asheducation-2005.1.307
Published: 2005
Journal Articles

Biology and Treatment of Chronic Lymphocytic Leukemia

Michael J. Keating, Nicholas Chiorazzi, Bradley Messmer, Rajendra N. Damle, Steven L. Allen, Kanti R. Rai, Manlio Ferrarini, Thomas J. Kipps
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2003) 2003 (1): 153–175.
https://doi.org/10.1182/asheducation-2003.1.153
Published: 2003